Overview

A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber

Status:
Completed

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

Summary

This study will compare the effectiveness of QAV680 against placebo in treating the symptoms of seasonal allergic rhinitis in an Environmental Exposure Chamber.

Phase:

Phase 2

Details

Lead Sponsor:

Novartis

Treatments:

Mometasone Furoate